FOLLOW US

Type 2 Diabetes Research Updates

For Medical Professionals

Two top diabetes educators offer strategies for CDEs to earn more income.
The detection of dysglycemia was found to be lower among racial/ethnic minorities using the new 2015 United States Preventive Services Task Force prediabetes and diabetes screening guidelines.
The protective effect of pioglitazone on risk for type 2 diabetes is reduced following treatment cessation, according to an extension of the ACT NOW trial.
A 6-month integrative health coaching intervention significantly improved medication adherence in adults with type 2 diabetes, and a significant decrease in hemoglobin A1C levels. The prospective observational trial was published in the BMJ Open Diabetes Research & Care.
The FDA added new warnings regarding an increased risk of hospitalization for heart failure to the drug labels for diabetes medications containing saxagliptin and alogliptin.
Data from more than 100,000 people with type 2 diabetes did not show an increased risk of fracture among those taking insulin versus oral antidiabetes agents.
Top 5 changes that endocrinologists, primary care providers, and other health care practitioners should know about.
High evening cortisol levels were predictive of new-onset type 2 diabetes in a prospective cohort study published in the February the Journal of Clinical Endocrinology and Metabolism.
A prepregnancy care program for women with type 1 and type 2 diabetes is effective and cost-effective, according to a prospective cohort and cost-analysis study.
Marked differences in 5-year survival rates were found among patients with diabetes based on the type of glucose-lowering agent they were prescribed.
SHOW MAIN MENU
SHOW SUB MENU